Press Release: Bio2 Technologies : Bio2 Technologies, Inc. Announces Receipt of FDA 510(k) Clearance for CLM Bioactive Scaffold

WOBURN, Mass., Dec. 19, 2014 /PRNewswire/ -- Bio2 Technologies, Inc. (a privately held development stage company) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for its CLM Bioactive Scaffold. CLM is constructed from bioactive...